ArticleClinical ophthalmology (Auckland, N.Z.)2025
Trends and Future Projections of Vitreoretinal Surgery in a Tertiary Hospital in China (2005-2022).
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyze past trends and project future trajectories of vitreoretinal surgery in China. Methods: A single-institution, retrospective analysis of vitreoretinal surgeries conducted at Zhongshan ophthalmic center (ZOC), Sun Yat-sen University, from 2005 to 2022, utilizing ZOC's inpatient database. Patients hospitalized in the retinal surgery department were included. The number of surgeries was stratified by final diagnosis, and a time series forecasting model was employed to predict the number of patients undergoing vitreoretinal surgery up to and including the year 2032. Results: The number of patients undergoing vitreoretinal surgery increased nearly fourfold from 2005 to 2022, reaching a total of 5600 vitreoretinal surgeries in 2022. The majority of indication was given for the treatment was rhegmatogenous retinal detachment (RRD). Among the diagnosis categories, macular diseases (MD) increased by 15.61%, and diabetic retinopathy (DR) by 11.99% during the study period. Vitreoretinal surgeries are projected to increased annually, with an estimated 9231 vitreoretinal surgeries by 2032. Conclusion: The demand for vitreoretinal surgery in China has grown substantially over the last decade and is anticipated to rise further. Healthcare systems must adapt to accommodate the high demand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.